# Comparative Arthroscopic Rotator Cuff Repair Outcomes Associated with Continuous Interscalene Block vs. Bolus Interscalene Block with Intravenous Dexmedetomidine: A Retrospective Cohort Study

**Authors:** Seong-Meen Yoon, Aeryoung Lee, Sungwook Choi

PMC · DOI: 10.3390/jcm14113882 · Journal of Clinical Medicine · 2025-05-30

## TL;DR

This study compared two anesthesia methods for rotator cuff surgery and found one used less morphine without worsening recovery.

## Contribution

Demonstrated that single-injection interscalene block with dexmedetomidine reduces morphine use without affecting pain or function.

## Key findings

- SISB group had significantly lower morphine consumption (18 mg vs. 24 mg in CISB group).
- No significant differences in postoperative pain, sleep disturbances, or functional outcomes between groups.
- Reduced opioid use in SISB group suggests fewer opioid-related side effects.

## Abstract

Background/Objectives: This retrospective cohort study compared the outcomes (postoperative pain, morphine consumption, sleep disturbance, and function) of patients undergoing arthroscopic rotator cuff repair involving either continuous interscalene block (CISB group) or single-injection interscalene block with intravenous dexmedetomidine (SISB group) analgesia. Methods: This study included 61 patients, aged 59–71 years, who underwent elective arthroscopic rotator cuff repair and for whom complete electronic health records were available. Patients in the SISB group received a single-injection nerve block plus intraoperative intravenous dexmedetomidine and postoperative patient-controlled analgesia (PCA; morphine and dexmedetomidine; n = 33). Patients in the CISB group received continuous nerve block and morphine PCA (n = 28). Patient sleep disturbances, pain, total morphine consumption, and functional outcomes were evaluated postoperatively. Results: During the first 36 h postoperatively, there were no significant differences in the measured effects for patients in the two groups. Similarly, there were no significant differences in functional outcomes. However, patients in the SISB group had a significantly lower median morphine consumption total (18 mg) than those in the CISB group (24 mg; p < 0.001). Conclusions: Patients in the SISB group demonstrated significantly lower median morphine consumption than those in the CISB group; however, the postoperative pain, frequency of sleep disturbances, nausea, and functional outcomes did not show statistically significant differences. The reduced morphine consumption associated with the SISB group, compared with the CISB group, suggests that this analgesic protocol may result in fewer opioid-related effects following arthroscopic rotator cuff repair.

## Linked entities

- **Chemicals:** morphine (PubChem CID 5288826), dexmedetomidine (PubChem CID 5311068)

## Full-text entities

- **Diseases:** nausea (MESH:D009325), postoperative pain (MESH:D010149), pain (MESH:D010146), Rotator Cuff (MESH:D000070636), sleep disturbance (MESH:D012893)
- **Chemicals:** Dexmedetomidine (MESH:D020927), CISB (-), morphine (MESH:D009020)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12156792/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12156792/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12156792/full.md

---
Source: https://tomesphere.com/paper/PMC12156792